Signaling Pathways - 5-HT7 Receptors - cannabinoid receptor - NOS - Myosin light chain kinases (MLCKs)
清除全部
-
B6345 L-NIO dihydrochlorideTarget: NOSSummary: 一氧化氮（NO）合酶抑制剂 -
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂 -
B6326 Diphenyleneiodonium chloride中文名: 二苯基氯化碘盐Target: NADPH Oxidases|NOS|GPR3Summary: iNOS和eNOS抑制剂，GPR3激动剂 -
B6369 7-Nitroindazole中文名: 硝基吲唑Target: NOSSummary: nNOS抑制剂 -
B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂 -
B1428 GW842166XTarget: cannabinoid receptorSummary: 大麻素受体激动剂 -
B1477 Lurasidone HCl中文名: 盐酸鲁拉西酮Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂 -
B1490 Quetiapine Fumarate1 Citation中文名: 富马酸奎硫平Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺受体拮抗剂 -
A3926 Vortioxetine中文名: 沃替西汀Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERTSummary: 5-HT受体拮抗剂 -
A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: 肌球蛋白轻链激酶抑制剂